|
|
Sunday, December 23, 2007 11:00pm — IP THINKTANK GLOBAL WEEK IN REVIEW
IP Think Tank Global Week in Review - 21 December 2007
Here is IP Think Tank’s weekly
selection of top intellectual property news breaking in the blogosphere and
internet.
Highlights this week included: talk of Thailand’s
potential move to compulsory licences for anticancer drugs, Canada’s DMCA put off until ’08 and China’s retialiatory blockade of Hollywood films.
Please join the discussion by adding your comments on any of these stories,
and please do let me know if you think we’ve missed something important, or if
there is a source you think should be monitored. You can separately subscribe to the IP Thinktank Global week in Review at http://feeds.feedburner.com/DuncanBucknellsGlobalWeekInReview Global - Events in Bali heap further pressure on all IP owners: (IAM),
- Velcro defies generic
claim in domain name battle: (OUT-LAW),
- ICANN forms group to
hasten non-English domain names: (IP
Justice)
- WTO members continue
debate on geographical indications register: (Intellectual
Property Watch),
- Creative Commons launches
CCo and CC programs: (World IP Day),
- Green IP Strategy – risks
and opportunities: (IP
ThinkTank),
- Shaping the terrain and
IP strategy: (IPThinkTank),
- WIPO consults on
protecting traditional knowledge, genetic resources: (Intellectual
Property Watch),
- Aligning IP strategy and
business strategy: (Financial
Aspects of IP),
- Open innovation and IP
strategy: (IPThinkTank),
- International
implications of Red Cross trade mark fight unclear: (Intellectual
Property Watch),
Pharma - Notes from the biotech
sector – ties between San Diego
and the PRC: (China Hearsay),
- ‘Microbesoft’ patents
could put the squeeze on synthetic life: (Ars
Technica),
- The Economic Times
reports that out of the 8000 drug patent applications filed in between
95-04 about 40% are by Indian companies: (Spicy
IP),
- Year 2007 in Pharmaceuticals:
(Profitability
through Simplicity),
- Depomed Inc. won summary
judgment in its patent suit against a Teva subsidiary over 2 patents for
AcuForm controlled-release technology: (IPLaw360),
- Guidelines for
examination of Pharma patents – a developing country’s perspective: (Generic
Pharmaceuticals & IP)
- Patented research tools
and the 271(e)(1) exemption: (Holman),
- Invitrogen and Genetic
Applications have settled the patent infringement suit over reissued patent
directed to methods of transplanting DNA into a eukaryotic genome to yield
hematopoietic cell lines: (Patent
Docs),
- Wyeth v Impax
Laboratories, Inc: ‘Extended release formulation’ and other terms defined
in ANDA case: (Delaware IP
Law)
- Busulfex (Busulfan) -
Otsuka Pharmeceutical Co and PDL BioPharma strike deal for IV Busulfex: (Patent
Docs),
- Celzentry - Pfizer
recently granted patent, by the Indian Patent office, for its HIV/AIDS
treatment drug Celzentry: (Spicy
IP),
- Cialis (Tadalafil) - Eli
Lilly’s patent application for an erectile dysfunction drug Cialis
rejected by the Indian Patent Office although this drug has been
successfully patented in the US, EU and Japan: (Spicy
IP),
- Detrol (Tolteradine) -
Generic company’s Detrol Polymorph patent highlights ongoing quality
issues in USPTO: (IPThinkTank),
- Gleevec / Glivec
(Imatinib) – Natco appeals to Supreme Court from High Court decision on
IPAB composition: (Generic
Pharmaceuticals & IP)
- Insulin - Wockhardt's
pre-grant opposition to Lilly's Human Insulin patent application was
rejected by the Kolkata Patent Office: (Generic
Pharmaceuticals & IP)
- Iressa (Gefitinib) - Astra’s
patent application for its lung cancer drug Iressa rejected by the Indian
Patent Office on grounds of ‘known prior use’: (Spicy
IP),
- Lyrica (Pregabalin) - Northwestern
University has sold part of its royalty rights to the pain therapy Lyrica
to Royalty Pharma for $700 million: (IP
Law360),
- Neopogen (Filgrastim) - Sloan-Kettering
Institute for Cancer Research sues Amgen Inc. for allegedly evading
royalty payments on infection preventative drugs, Neupogen and Neulasta: (IP
Law360),
- Seasonale
(ethinylestradiol) - Barr sues to block generic Seasonale: (IP
Law360),
- Sular (Nisoldipine) –
Sciele sues Mylan over ANDA filing: (Generic
Pharmaceuticals & IP)
- Tarka (Trandolapril &
Verapamil) - Sanofi-Aventis SA and Abbott Laboratories have jointly filed
a lawsuit against Glenmark to prevent the Indian company from selling a
generic version of its hypertension drug Tarka in the US: (Spicy
IP),
Canada Canada’s DMCA and surrounding
controversy: (Now why didn’t I
think of that?), Canadian Association of
University Teachers on copyright reform: (Michael Geist), Cisco on copyright in Canada:
(Michael Geist), - The new copyright debate:
(Michael Geist),
- Media coverage of
copyright debate: (Michael Geist),
(more from Michael
Geist), (and more from Michael Geist),
(and more from Michael
Geist),
- Copyright delay
demonstrates power of Facebook: (Michael Geist),
- Access Copyright claims
copyright reforms may be on hold ‘indefinitely’: (Michael Geist),
- Canadian Independent
Records Production Association criticizes copyright delay: (Michael Geist),
- Growing calls for
Copyright Commission: (Michael Geist)
- Update on gray marketing:
(Mondaq.com),
- Canadian Patent Office issues
Practice Notice regarding signal claims: (Mondaq.com),
- Official marks
developments: (Mondaq.com),
- Canadian porn spammers’
lust for Facebook data lands them in court: (Ars
Technica),
- Amendments to the Trade
Marks Regulations: (Mondaq.com),
- Amendments to the Patent
Rules: (Mondaq.com),
- Fasken Martineau’s The IP
Year 2007 in Review: Trade Marks: (Mondaq.com),
- Fasken Martineau’s The IP
Year 2007 in Review: Patents: (Mondaq.com),
- Fasken Martineau’s The IP
Year 2007 in Review: Copyright: (Mondaq.com),
China
China hits back by banning Hollywood films in
ongoing IP dispute: (IAM),
(Ars
Technica), - Tech transfer and the
environment: (China Hearsay),
- A brave new future for China
in science: (ajc.com),
- Lack of Chinese patent
costs Schneider Electric dearly: (IP
Dragon)
- China IT outsourcing rising
(including discussion of associated IP issues): (China
Law Blog),
- Cheng Yongshun’s critique
on US Patent Reform Act ammunition to opposites: (IP
Dragon),
- IP litigation data: what it
means (interpretation of statistics collected from Beijing People’s
Courts’ decisions in IP disputes): (Experience
not logic), and related commentary (China
Law Blog), (IP
Dragon), (IAM),
(Peter
Zura’s 271 Patent Blog)
- Writers sue Beijing Sursen
Electronic Technology Company for copyright infringement on its website: (China Hearsay),
China does its part re: TRIPs
& compulsory licensing: (China
Hearsay), - Analysis of Danone v Wahaha:
(China
Law Blog), (Spicy
IP)
China a victim of Basmati Rice
Syndrome: (China Hearsay), - Data key on road to IPR
transparency: (IP
Dragon),
- GOOG v Guge: Chinese
company sues Google over name: (Ars
Technica),
China, US hold high-level
discussions on IP issues: (Intellectual
Property Watch), - Wembley Gypsum Products v
MST Industrial Systems: (Mondaq.com),
- Fake pens in China write/writ large –China’s current status
regarding counterfeiting: (China
Law Blog),
- Yahoo! found guilty of mass
copyright infringement: (TorrentFreak),
Europe Finland
- Employee
inventions: main rule regarding inventions: (Mondaq.com)
France - Profession of patent
attorneys to be abolished?: (BLOG@IP::JUR)
India Korea
Malaysia
- Music Authors Copyright Protection Bhd has
called on 100 entertainment outlets to settle their outstanding royalty
payments: (Mondaq.com),
- Malaysia has established an Intellectual
Property Court: (Mondaq.com),
Netherlands
- Amendment to Netherlands Patent Act 1995:
Abandonment of 6-years-patent and other changes: (BLOG@IP::JUR)
Thailand
United Kingdom
- UK-IPO/EPO patentability
rift widens: (IPKat),
- It’s official: buying
fakes can damage your health (according to a UK government warning): (IPKat),
- Shaping policy; changing
policy – the UK IPO establishment of the Strategic Advisory Board on IP
Policy: (IPKat),
- Warring parties wave
their weapons when IP licences come unstuck – the High Court’s decision in
design and copyright infringement case Societa Esplosivi Industriali
SpA v Ordinance Technologies (UK) Limited: (IPKat);
- Tech firms challenge
software patent barrier in High Court: (OUT-LAW),
- Data protection law will
be reviewed: (OUT-LAW),
- Developer keeps software
rights as implied term argument fails in court (Meridian International
Services Ltd v Ian Richardson & Ors): (OUT-LAW),
- World Cup Willie company
loses case on own evidence – High Court rules goodwill in trade marks can
last for 40 years even if the mark is rarely used in that time: (OUT-LAW),
United States
- Shaping policy; changing
policy – US Dept of Justice rejects plans to strengthen its IP
enforcement: (IPKat),
- Consumer groups urge
Supreme Court not to make it illegal to sell second-hand patented goods: (OUT-LAW),
- Blogger warned to delete
Avis logo: (OUT-LAW),
- Cover version was too
close to the original, argues Guitar Hero lawsuit: (OUT-LAW),
- No licence required to
run a fantasy league – in US or UK: (OUT-LAW), (IP
Law Blog)
- Business should fund
domain name police, says expert: (OUT-LAW),
- Simultaneous publication:
(Patry
Copyright Blog),
- Sampling without a
licence results in damages – but how punitive should they be?: (Mondaq.com),
- Kinsella way off on
patent reform (and continuing debate): (IPBiz),
(more from IPBiz),
(and more from IPBiz)
- Orbitz answers Global
Patent Holdings’ JPEG-on-a-website complaint, explains why infringement is
impossible: (Patent
Troll Tracker),
- Statute of Limitations
for actions between co-owners: (Patry
Copyright Blog),
- USPTO Rules changes
stopped by injunction: (Mondaq.com),
(more from Mondaq.com)
- Statute of limitations
for trade secrets misappropriation begins accruing on the date injury
occurs: (Mondaq.com),
- A ‘reconstruction’ does
not fulfill copyright application deposit requirement: (Mondaq.com),
- Paper: disregard for
customers, DMCA led to Sony CD rootkit: (Ars
Technica),
- The shifting scope of
patentable subject matter: (IP
Law360),
- Famous marks doctrine not
recognized by a New York
appellate court: (IP
Law360),
- Arising under
jurisdiction, copyright, and community property: (Patry
Copyright Blog),
- Patent reform legislation
stalled: (Mondaq.com),
- Guestbridge settles
internet reservations patent suit against Online Reservations: (IP
Law360),
- The global garrottig of
the public domain: (Patry
Copyright Blog),
- Congress considers Bill
to make radio ‘pay to play’: (Ars
Technica), (IP
Law360),
- Recommended reading: Scot
Duvall on the Trademark Dilution Revision Act of 2006: (TTABlog),
- Neil Netanel’s “Why has
copyright expanded?’: (Patry),
- US Federal Court throws
out lawsuit challenging Margaret Peterlin’s appointment as deputy director
of the USPTO: (Intellectual
Property Watch),
- Top ten patent trolls of
2007: (Patent
Troll Tracker),
- 9 th Circuit:
No attorneys fees when plaintiff elects to recover statutory damages for
trade mark counterfeiting: (ADR
Blog),
- Should Yahoo! Be able to
patent ‘smart drag and drop’? How you can help the US Patent Office reject
a bogus patent claim: (LawGeek),
- Should copyright owners
have to give notice about their use of technical protection measures? (LawGeek),
- Peer to Patent Project: (The Legal Thing),
- US approves
Google/DoubleClick deal; EU still deciding: (Ars
Technica),
- Crafty strategy needed
for new IDS rules at USPTO?: (IPBiz)
- Will Seattle become a favoured forum for
patent litigation?: (Washington
State Patent Law Blog),
- Five more suggestions for
a better patent system: (PLI
Patent Practice Center),
- Chinese IP Judge
discusses implications of US Patent Reform Bill and two congressman heed
warning: (Patent
Docs),
- Comparison of defensive
publication mechanisms: (IP
Updates),
- When is an electronic
document a printed publication for prior art purposes?: (Patently–O),
- Does size matter?
Counting words in patent specifications: (Patently-O)
- Which top NYSE 100
companies were sued the most in 2007 for patent infringement?: (Patent
Troll Tracker),
0 Comments
0 Trackbacks
trackback url: http://duncanbucknell.com/trackback.php?id=215
|
|